Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
8-K - OSR Holdings, Inc. (0001840425) (Filer)
25-NSE - OSR Holdings, Inc. (0001840425) (Subject)
425 - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)
3 - OSR Holdings, Inc. (0001840425) (Issuer)
3 - OSR Holdings, Inc. (0001840425) (Issuer)
3 - OSR Holdings, Inc. (0001840425) (Issuer)
BELLEVUE, Wash. and ZUG, Switzerland, July 8, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced the official roadmap for a targeted $50 million security token offering (STO) planned for launch in the second half of 2025 under Regulation D of the U.S. Securities Act. The token, with the working title OSRT, will be a securitized digital asset representing OSR Holdings' equity exposure and is designed to align with the company's blockchain-based capital strategy. As part of this roadmap
SEOUL, South Korea and ZUG, Switzerland, May 22, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH), a public company dedicated to advancing innovation in healthcare and wellness, announced today that it has entered into a Memorandum of Understanding (MOU) with BCM Europe AG, its major shareholder, and Taekwondo Cooperative (TKD Coop), a global Taekwondo community organization, to explore the joint development of a security token, provisionally named the "OSRH Token". The initiative aims to enhance access to crypto-based liquidity and provide a basis for OSRH to launch crypto treasury strategies.
OSR Holdings, Inc. to Begin Trading on the Nasdaq Stock Market LLC on Tuesday, February 18, 2025Under the symbol "OSRH" SEOUL, South Korea, Feb. 14, 2025 /PRNewswire/ -- OSR Holdings, Inc. (formerly Bellevue Life Sciences Acquisition Corp. (the "Company")) and OSR Holdings Co., Ltd. ("OSR") announced today the completion of their business combination (the "Business Combination"). The Company now operates as "OSR Holdings, Inc." following the successful completion of the Business Combination. Beginning on Tuesday, February 18, 2025, the common stock and warrants of the Company
SC 13G - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)
SC 13G/A - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)
SC 13G - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)